Cargando…

The Impact Exerted on Clinical Outcomes of Patients With Chronic Heart Failure by Aldosterone Receptor Antagonists: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Aldosterone receptor antagonists (ARAs) have been associated with improved clinical outcomes in patients with heart failure with reduced left ventricular ejection fraction (HFREF), but not in those with heart failure with preserved left ventricular ejection fraction (HFpEF). With the aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Vecchis, Renato, Cantatrione, Claudio, Mazzei, Damiana, Barone, Augusto, Maurea, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215017/ https://www.ncbi.nlm.nih.gov/pubmed/28090229 http://dx.doi.org/10.14740/jocmr2851w

Ejemplares similares

Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?
por: De Vecchis, Renato, et al.
Publicado: (2016)

Non-Ergot Dopamine Agonists Do Not Increase the Risk of Heart Failure in Parkinson’s Disease Patients: A Meta-Analysis of Randomized Controlled Trials
por: De Vecchis, Renato, et al.
Publicado: (2016)

Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent
por: De Vecchis, Renato, et al.
Publicado: (2016)

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
por: Nappi, Jean M, et al.
Publicado: (2011)

Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?
por: De Vecchis, Renato, et al.
Publicado: (2017)

Treatment of heart failure with ACE inhibitors and beta-blockers: What is next? Aldosterone receptor antagonists?
por: van der Horst, Iwan C. C., et al.
Publicado: (2007)

Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan
por: Mayyas, Fadia, et al.
Publicado: (2017)

Therapeutic benefits of phosphodiesterase-5 inhibition in chronic heart failure: A meta-analysis
por: Vecchis, Renato De, et al.
Publicado: (2017)

Aldosterone receptor antagonists: current perspectives and therapies
por: Guichard, Jason L, et al.
Publicado: (2013)

Aldosterone antagonism in heart failure
por: Miller, Alan B
Publicado: (2007)

Evaluation of aldosterone antagonist utilization in heart failure with reduced and preserved ejection fraction at an academic medical center
por: Bradley, Daniel, et al.
Publicado: (2019)

Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
por: Berbenetz, Nicolas M., et al.
Publicado: (2016)

Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure
por: Boorsma, Eva M., et al.
Publicado: (2021)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2021)

Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists
por: Yoshida, Yuichi, et al.
Publicado: (2021)

Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Le, Hai-Ha, et al.
Publicado: (2016)

Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial
por: Sandesara, Pratik B., et al.
Publicado: (2018)

Myocardial Aldosterone Receptor and Aquaporin 1 Up-Regulation Is Associated with Cardiomyocyte Remodeling in Human Heart Failure
por: Frustaci, Andrea, et al.
Publicado: (2021)

SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism Screening
por: Tezuka, Yuta, et al.
Publicado: (2020)

Diuretic dosing in heart failure: more data are needed
por: De Vecchis, Renato, et al.
Publicado: (2018)

Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials
Publicado: (2023)

Impact of Mineralocorticoid Receptor Antagonists in the Treatment of Heart Failure: Targeting the Heart Failure Cascade
por: Jadhav, Uday, et al.
Publicado: (2023)

Comorbidity “depression” in heart failure — Potential target of patient education and self-management
por: De Vecchis, Renato, et al.
Publicado: (2017)

Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis
por: De Vecchis, Renato, et al.
Publicado: (2017)

The Aldosterone-Mineralocorticoid Receptor Pathway Exerts Anti-Inflammatory Effects in Endotoxin-Induced Uveitis
por: Bousquet, Elodie, et al.
Publicado: (2012)

PSUN68 Finerenone for Primary Aldosteronism: A Novel Mineralocorticoid Receptor Antagonist
por: Aurora, John, et al.
Publicado: (2022)

Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review
por: Mai, Xurong, et al.
Publicado: (2022)

Beta-adrenergic receptor antagonists and chronic heart failure in children
por: Filippo, Sylvie Di
Publicado: (2007)

Mineralocorticoid receptor antagonist use following heart failure hospitalization
por: Duran, Jason M., et al.
Publicado: (2020)

The place of ARBs in heart failure therapy: is aldosterone suppression the key?
por: Markan, Uma, et al.
Publicado: (2019)

Renin-angiotensin-aldosterone system and kidney interactions in heart failure
por: Ferreira, João Pedro, et al.
Publicado: (2019)

Incidental Congestive Heart Failure in Patients With Aldosterone‐Producing Adenomas
por: Huang, Wei‐Chieh, et al.
Publicado: (2019)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
por: Andersen, Stine, et al.
Publicado: (2016)

Aldosterone Antagonists Reduce the Risk of Cardiovascular Mortality in Dialysis Patients: A Meta-Analysis
por: Li, Yan, et al.
Publicado: (2019)

Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis
por: Jansen, Pieter M., et al.
Publicado: (2011)

Rates of hospitalization associated with the use of aldosterone receptor antagonists in patients with pulmonary arterial hypertension
por: Corkish, Morgan E., et al.
Publicado: (2019)

A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
por: Epstein, Murray
Publicado: (2022)

Mineralocorticoid receptor antagonists for chronic heart failure: a meta-analysis focusing on the number needed to treat
por: Geng, Chang, et al.
Publicado: (2023)

Sacubitril/Valsartan Therapy for 14 Months Induces a Marked Improvement of Global Longitudinal Strain in Patients With Chronic Heart Failure: A Retrospective Cohort Study
por: De Vecchis, Renato, et al.
Publicado: (2019)

Aldosterone exerts anti-inflammatory effects on LPS stimulated microglia
por: Bast, Björn-Ole, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6q2hhd253tn5i7736eln61n4iu